These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
318 related items for PubMed ID: 26729319
1. Neutrophil-to-lymphocyte ratio predicts recurrence after radiofrequency ablation in hepatitis B virus infection. Tajiri K, Baba H, Kawai K, Minemura M, Yasumura S, Takahara T, Sugiyama T. J Gastroenterol Hepatol; 2016 Jul; 31(7):1291-9. PubMed ID: 26729319 [Abstract] [Full Text] [Related]
2. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma. Lee S, Rhim H, Kim YS, Kang TW, Song KD. Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910 [Abstract] [Full Text] [Related]
3. Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation. Chen TM, Lin CC, Huang PT, Wen CF. J Gastroenterol Hepatol; 2012 Mar; 27(3):553-61. PubMed ID: 21913982 [Abstract] [Full Text] [Related]
4. Comparison of prognosis by viral etiology in patients with hepatocellular carcinoma after radiofrequency ablation. Chen PH, Kao WY, Chiou YY, Hung HH, Su CW, Chou YH, Huo TI, Huang YH, Wu WC, Chao Y, Lin HC, Wu JC. Ann Hepatol; 2013 Mar; 12(2):263-73. PubMed ID: 23396738 [Abstract] [Full Text] [Related]
5. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy. Chung GE, Kim W, Lee JH, Kim YJ, Yoon JH, Lee JM, Lee JY, Kim SH, Kim D, Lee HS. J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297 [Abstract] [Full Text] [Related]
6. Low serum interleukin-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related hepatocellular carcinoma who underwent curative treatment. Cho HJ, Kim SS, Ahn SJ, Park SY, Park JH, Kim JK, Wang HJ, Cheong JY, Cho SW. Cytokine; 2015 Jun; 73(2):245-52. PubMed ID: 25797190 [Abstract] [Full Text] [Related]
7. High serum hyaluronic acid and HBV viral load are main prognostic factors of local recurrence after complete radiofrequency ablation of hepatitis B-related small hepatocellular carcinoma. Xia F, Lai EC, Lau WY, Ma K, Li X, Bie P, Qian C. Ann Surg Oncol; 2012 Apr; 19(4):1284-91. PubMed ID: 21913016 [Abstract] [Full Text] [Related]
8. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio. Harimoto N, Shirabe K, Nakagawara H, Toshima T, Yamashita Y, Ikegami T, Yoshizumi T, Soejima Y, Ikeda T, Maehara Y. Transplantation; 2013 Dec 15; 96(11):1008-12. PubMed ID: 24113512 [Abstract] [Full Text] [Related]
10. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection. Ji F, Fu S, Guo Z, Pang H, Chen D, Wang X, Ju W, Wang D, He X, Hua Y, Peng B. Oncotarget; 2016 Nov 01; 7(44):72276-72289. PubMed ID: 27472390 [Abstract] [Full Text] [Related]
11. Predisposing factors for recurrence of HBV-related small hepatocellular carcinoma after percutaneous radiofrequency ablation. Sohn W, Paik YH, Lee MW, Rhim H, Lim HK, Cho JY, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Scand J Gastroenterol; 2014 Mar 01; 49(3):373-80. PubMed ID: 24354931 [Abstract] [Full Text] [Related]
12. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation. Seo JY, Kim W, Kwon JH, Jin EH, Yu SJ, Kim HY, Jung YJ, Kim D, Kim YJ, Yoon JH, Lee HS. Liver Int; 2013 Jul 01; 33(6):884-93. PubMed ID: 23461618 [Abstract] [Full Text] [Related]
13. Association between nucleos(t)ide analog and tumor recurrence in hepatitis B virus-related hepatocellular carcinoma after radiofrequency ablation. Lee TY, Lin JT, Zeng YS, Chen YJ, Wu MS, Wu CY. Hepatology; 2016 May 01; 63(5):1517-27. PubMed ID: 26426978 [Abstract] [Full Text] [Related]
14. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients. Meguro M, Mizuguchi T, Nishidate T, Okita K, Ishii M, Ota S, Ueki T, Akizuki E, Hirata K. World J Gastroenterol; 2015 Apr 28; 21(16):4933-45. PubMed ID: 25945007 [Abstract] [Full Text] [Related]
15. Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation. Xiao GQ, Liu C, Liu DL, Yang JY, Yan LN. World J Gastroenterol; 2013 Dec 07; 19(45):8398-407. PubMed ID: 24363533 [Abstract] [Full Text] [Related]
16. Prognostic impact of surgery and radiofrequency ablation on single nodular HCC ⩽5 cm: Cohort study based on serum HCC markers. Ueno M, Hayami S, Shigekawa Y, Kawai M, Hirono S, Okada K, Tamai H, Shingaki N, Mori Y, Ichinose M, Yamaue H. J Hepatol; 2015 Dec 07; 63(6):1352-9. PubMed ID: 26212030 [Abstract] [Full Text] [Related]
17. Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma. Xiao GQ, Yang JY, Yan LN. Hepatobiliary Pancreat Dis Int; 2015 Dec 07; 14(6):588-95. PubMed ID: 26663006 [Abstract] [Full Text] [Related]
18. [Comparison of prognosis of small hepatocellular carcinoma patients with hepatitis B virus infection versus hepatitis C virus infection]. Li HK, Qin Y, Li XM, Li Q. Zhonghua Gan Zang Bing Za Zhi; 2009 Jun 07; 17(6):426-8. PubMed ID: 19567020 [Abstract] [Full Text] [Related]
19. Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study. Dan JQ, Zhang YJ, Huang JT, Chen MS, Gao HJ, Peng ZW, Xu L, Lau WY. Eur J Surg Oncol; 2013 Aug 07; 39(8):865-72. PubMed ID: 23597497 [Abstract] [Full Text] [Related]
20. Preablation neutrophil-to-lymphocyte ratio as an independent prognostic factor in locally advanced hepatocellular carcinoma patients following radiofrequency ablation. Tan W, Sun W, Li X, Zhao L, Wang C, Zang A, Kong X. J Cancer Res Ther; 2018 Jan 07; 14(1):84-89. PubMed ID: 29516965 [Abstract] [Full Text] [Related] Page: [Next] [New Search]